Trastuzumab - Globe Thesis

Keyword [Trastuzumab] Result: 61 - 80 \| Page: 4 of 8
61.	The Anti-proliferative Effect And Mechanisms Of Metformin On Human HER2 Positive Gastric Cancer
62.	Activation Of PI3K/AKT Pathway Promotes Trastuzumab Resistance In HER2-positive Gastric Cancer
63.	Finding Predictive Biomarkers For Trastuzumab Resistance In A Breast Cancer Cell Line
64.	PIK3R3-STAT3 Feedback Loop Mediates Trastuzumab Resistance
65.	Study On The Association And Molecular Mechanism Of LncRNA HOTAIR And Trastuzumab Resistance In Breast Cancer
66.	Exploring The Regulation Of Cyclin D3 By Trastuzumab And The Mechanism Of Trastuzumab Resistance In Breast Cell Line
67.	Preparation Of Trastuzumab-bearing Paclitaxel-loaded Lipid Nanoparticles And Preliminary Study Of Targeting
68.	The Anti-tumor Effect Of Anti-ErbB2 Antibody H2-18 In Combination With Small Molecule Inhibitors On Trastuzumab-resistant Breast Cancer And Mechanism Of Action
69.	Splicing Factor HnRNPA2B1 Contributes To The Tumorigenic Potential Of Breast Cancer Cells Through The STAT3 And ERK1/2 Signaling Pathway
70.	Study On Prognostic Indicators Of Breast Cancer
71.	Acute Cardiotoxicity In The Setting Of Concurrent Trastuzumab And Posto Perative Adjuvant Therapy Of Breast Cancer
72.	The Clinical Observation Of Trastuzumab In First-line Treatment Of Her-2 Positive Metastatic Breast Cancer
73.	The Predictive Value Of Combined Biomarker Detection On Cardiotoxicity Induced By Trastuzumab And Chemotherapy In Early Breast Cancer
74.	The Combination Effect Of Trastuzumab And Oxaliplatin On Cell Proliferation And Viability In HER2-positive Gastric Cancer
75.	Retrospective Study Of Trastuzumab Combined With Chemotherapy In The Treatment Of HER2-positive Advanced Gastric Cancer Clinical Efficacy,Safety And Treatment Before And After The HER2 State And Drug Resistance Gene
76.	High Plasma Fibrinogen Is Correlated With Poor Response To Trastuzumab Treatment In HER2 Positive Breast Cancer
77.	The Mechanism Study Of The NRG1/HER3 Activation In The Primary Resistance Of HER2-positive Breast Cancer To Trastuzumab
78.	An Observational Study Of Cardiotoxicity In Breast Cancer Patients Using Herceptin Following Anthracycline
79.	Nuclide Labeling And SPECT/CT Molecular Imaging Of HER2 Targeting Biomolecules
80.	The Anti-tumor Effect Of Anti-HER2 Antibody H2-18 On Gastric Cancer And Its Mechanism
<<First <Prev Next> Last>> Jump to